Source:http://linkedlifedata.com/resource/pubmed/id/10218945
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-5-6
|
pubmed:abstractText |
Insulin-like growth factor I (IGF-I) has been implicated as a factor that may predispose one to prostate cancer. However, no specific relationship between IGF-I and prostate development or cancer in vivo has been established. To determine whether IGF-I was important in prostate development, we examined prostate architecture in IGF-I(-/-) null mice and wild-type littermates. Glands from 44-day-old IGF-I-deficient animals were not only smaller than those from wild-type mice, but also had fewer terminal duct tips and branch points and deficits in tertiary and quaternary branching (P < 0.0001), indicating a specific impairment in gland structure. Administration of des(1-3)-IGF-I for 7 days partially reversed the deficit by increasing those parameters of prostate development (P < 0.006). That IGF-I production probably mediates an effect of GH in this process was indicated by the observations that GH antagonist transgenic mice also had significantly impaired prostate development (P < 0.0002) and that bovine GH had no independent effect on stimulating prostate development in IGF-I null animals. The data indicate that IGF-I deficiency is the proximate cause of impaired prostate development and give credence to the idea that, like testosterone, GH and IGF-I may be involved in prostate cancer growth as an extension of a normal process.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/insulin-like growth factor 1...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1984-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10218945-Animals,
pubmed-meshheading:10218945-Body Constitution,
pubmed-meshheading:10218945-Body Weight,
pubmed-meshheading:10218945-Cattle,
pubmed-meshheading:10218945-Female,
pubmed-meshheading:10218945-Growth Hormone,
pubmed-meshheading:10218945-Insulin-Like Growth Factor I,
pubmed-meshheading:10218945-Male,
pubmed-meshheading:10218945-Mice,
pubmed-meshheading:10218945-Mice, Inbred C57BL,
pubmed-meshheading:10218945-Mice, Knockout,
pubmed-meshheading:10218945-Mice, Transgenic,
pubmed-meshheading:10218945-Peptide Fragments,
pubmed-meshheading:10218945-Prostate
|
pubmed:year |
1999
|
pubmed:articleTitle |
Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development.
|
pubmed:affiliation |
Department of Medicine, New York University School of Medicine, and the Department of Veterans Affairs Medical Center, New York 10016, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|